A2i Therapeutics
PrivateCompany Overview
A2i Therapeutics is a drug discovery company that develops small-molecule immuno-oncology agents using an artificial intelligence platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
A2i Therapeutics Comparables
Compare A2i Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| STORM Therapeutics | 76% | |
| Risen (Shanghai) Pharma Tech Co., Ltd. | 76% | |
| BridGene Biosciences | 73% |
A2i Therapeutics Funding Rounds
Historical fundraising activity
A2i Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about A2i Therapeutics's valuation, stock price, and market status.
Is A2i Therapeutics a public or private company?
A2i Therapeutics is a private company.
What is the current stock price of A2i Therapeutics?
A2i Therapeutics is a private company, so its shares have no public market price. Caplight tracks A2i Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is A2i Therapeutics worth (valuation)?
Valuation information for A2i Therapeutics is not publicly available.
Can I buy A2i Therapeutics stock?
A2i Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was A2i Therapeutics's last funding round?
Funding round information for A2i Therapeutics is not publicly available.
Who are the main investors in A2i Therapeutics?
Investor information for A2i Therapeutics is not publicly disclosed.
Will A2i Therapeutics IPO soon?
No public IPO plans have been announced for A2i Therapeutics.
How can I track A2i Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in A2i Therapeutics's shares on secondary markets.